当前位置:首页 - 行情中心 - 天坛生物(600161) - 财务分析 - 现金流量表

天坛生物

(600161)

  

流通市值:376.29亿  总市值:376.29亿
流通股本:19.77亿   总股本:19.77亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,736,558,359.18681,035,737.884,930,664,034.174,018,855,673.47
  收到的税费返还-7,800--
  收到其他与经营活动有关的现金49,939,140.2821,960,381.56134,759,387.68107,312,335.06
  经营活动现金流入小计1,786,497,499.46703,003,919.445,065,423,421.854,126,168,008.53
  购买商品、接受劳务支付的现金1,039,889,364.45503,200,062.742,222,626,557.331,569,884,073.09
  支付给职工以及为职工支付的现金445,464,366.1238,229,201.951,135,421,616.41605,225,669.4
  支付的各项税费399,920,918.5218,444,163.72636,711,015.97476,836,525.71
  支付其他与经营活动有关的现金103,127,400.5344,770,204.23250,883,527.05175,469,960.83
  经营活动现金流出小计1,988,402,049.581,004,643,632.644,245,642,716.762,827,416,229.03
  经营活动产生的现金流量净额-201,904,550.12-301,639,713.2819,780,705.091,298,751,779.5
二、投资活动产生的现金流量:
  收回投资收到的现金--25,330,30825,330,308
  取得投资收益收到的现金37,100,956.96-21,500,00021,500,000
  处置固定资产、无形资产和其他长期资产收回的现金净额79,930.752,446.7159,941.3132,729
  收到的其他与投资活动有关的现金700,000,000-1,000,000,0001,000,000,000
  投资活动现金流入小计737,180,887.6652,446.71,046,990,249.31,046,963,037
  购建固定资产、无形资产和其他长期资产支付的现金325,460,519.56144,405,613.981,067,411,262.82734,275,672.1
  取得子公司及其他营业单位支付的现金--963,780,936.995,163,446.68
  支付其他与投资活动有关的现金--874,914,240532,000,000
  投资活动现金流出小计325,460,519.56144,405,613.982,906,106,439.811,271,439,118.78
  投资活动产生的现金流量净额411,720,368.1-144,353,167.28-1,859,116,190.51-224,476,081.78
三、筹资活动产生的现金流量:
  取得借款收到的现金42,137,862.6334,737,094.71--
  筹资活动现金流入平衡项目00--
  筹资活动现金流入小计42,137,862.6334,737,094.71--
  分配股利、利润或偿付利息支付的现金304,247,963.18-352,531,629.09352,160,858.89
  其中:子公司支付给少数股东的股利、利润107,143,523.23-105,360,198.39104,989,428.19
  支付其他与筹资活动有关的现金10,930,606.632,068,648.4717,755,213.7814,140,184.08
  筹资活动现金流出小计315,178,569.812,068,648.47370,286,842.87366,301,042.97
  筹资活动产生的现金流量净额-273,040,707.1832,668,446.24-370,286,842.87-366,301,042.97
四、汇率变动对现金及现金等价物的影响-2,279.48370.01-43,795.73-62,388.04
五、现金及现金等价物净增加额-63,227,168.68-413,324,064.23-1,409,666,124.02707,912,266.71
  加:期初现金及现金等价物余额1,422,920,905.041,422,920,905.042,832,587,029.062,832,587,029.06
  期末现金及现金等价物余额1,359,693,736.361,009,596,840.811,422,920,905.043,540,499,295.77
补充资料:
  净利润865,800,086.14-2,112,264,516.35-
  资产减值准备33,550,584.65-53,018,376.3-
  固定资产和投资性房地产折旧163,520,008.34-254,203,356.88-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧163,520,008.34-254,203,356.88-
  无形资产摊销37,830,420.75-58,342,884.7-
  长期待摊费用摊销16,831,522.75-31,302,677.14-
  处置固定资产、无形资产和其他长期资产的损失-204,679.09--37,503.49-
  固定资产报废损失54,096.04-7,366,601.69-
  财务费用4,340,269.9-4,685,090.88-
  投资损失-22,432,891.35--63,926,881.42-
  递延所得税-10,792,107.38-2,303,381.97-
  其中:递延所得税资产减少-4,514,683.67-5,649,907.66-
    递延所得税负债增加-6,277,423.71--3,346,525.69-
  存货的减少-40,628,592.84--579,842,533.14-
  经营性应收项目的减少-1,340,914,398.19--473,117,126.79-
  经营性应付项目的增加78,271,390.42--613,096,821.24-
  现金的期末余额1,359,693,736.36-1,422,920,905.04-
  减:现金的期初余额1,422,920,905.04-2,832,587,029.06-
  现金及现金等价物的净增加额-63,227,168.68--1,409,666,124.02-
公告日期2025-08-222025-04-262025-03-292024-10-26
审计意见(境内)标准无保留意见
TOP↑